Isomorphic Labs brings the AI, MSD brings the data in drug-discovery tie-up
The research collaboration pairs Isomorphic’s drug-design technology with MSD’s proprietary data and pharmaceutical expertise, according to Isomorphic.
TLDR
Isomorphic Labs announced a research collaboration with MSD on November 19, 2026, pairing its AI drug-design approach with MSD’s proprietary data and pharmaceutical expertise. The company’s pitch is faster progress on potential treatments. Its announcement webpage includes no performance evaluation or clinical findings from the collaboration.
Combined views
473
3 Sources, first seen ago


Comments